Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides

Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975

Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions

Saudou, F., Finkbeiner, S. M., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,598

Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy

Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Controlling Amyloid‐β Peptide(1–42) Oligomerization and Toxicity by Fluorinated Nanoparticles

Saraiva, A. M., Cardoso, I., Pereira, M. D. C., Coelho, M. A. N., Saraiva, M. J., Möhwald, H., & Brezesinski, G. (2010) · ChemBioChem · doi:10.1002/cbic.201000237 · Cited by 41

Soluble oligomeric forms of beta-amyloid (Aβ) peptide stimulate Aβ production via astrogliosis in the rat brain

Pérez, J. L. M., Carrero, I., Gonzalo, P., Arévalo‐Serrano, J., Anquela, J. M. S., Ortega, F. J., Rodríguez, M. J., & Gonzalo‐Ruiz, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.10.013 · Cited by 44

Exceptional Amyloid β Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds

Taguchi, H., Planque, S. A., Sapparapu, G., Boivin, S., Hara, M., Nishiyama, Y., & Paul, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806766200 · Cited by 41

Zn2+-Aβ40 Complexes Form Metastable Quasi-spherical Oligomers That Are Cytotoxic to Cultured Hippocampal Neurons

Solomonov, I., Korkotian, E., Born, B., Feldman, Y., Bitler, A., Rahimi, F., Li, H., Bitan, G., & Sagi, I. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344036 · Cited by 41

Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1–3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu2+

Dong, M., Li, H., Hu, D., Zhao, W., Zhu, X., & Ai, H. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00343 · Cited by 41

The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity

Qu, A., Huang, F., Li, A., Yang, H., Zhou, H., Long, J., & Shi, L. (2016) · Chemical Communications · doi:10.1039/c6cc07803f · Cited by 42

Unconjugated PLGA nanoparticles attenuate temperature-dependent β-amyloid aggregation and protect neurons against toxicity: implications for Alzheimer’s disease pathology

Paul, P. S., Cho, J., Wu, Q., Karthivashan, G., Grabovac, E., Wille, H., Kulka, M., & Kar, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01269-0 · Cited by 41

β-Amyloid Inhibits Protein Prenylation and Induces Cholesterol Sequestration by Impairing SREBP-2 Cleavage

Mohamed, A., Saavedra, L., Pardo, A. D., Sipione, S., & Chaves, E. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0630-12.2012 · Cited by 44

Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain

Sarkar, P., Narayanan, J., & Harder, D. R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.058 · Cited by 42

Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid β-related Behavioral Deficits in a Mouse Model of Alzheimer Disease

Basi, G. S., Feinberg, H., Oshidari, F., Anderson, J., Barbour, R., Baker, J., Comery, T. A., Diep, L., Gill, D. S., Johnson‐Wood, K., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045187 · Cited by 45

Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques

Shin, M., Kim, H. G., Baek, S. H., Jung, W.-R., Park, D. I., Park, J., Jo, D., & Kim, K.-L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.091 · Cited by 42

Formation of Toxic Amyloid Fibrils by Amyloid β‐Protein on Ganglioside Clusters

Matsuzaki, K. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/956104 · Cited by 40

TRP Channels as Emerging Therapeutic Targets for Neurodegenerative Diseases

Hong, C., Jeong, B., Park, H. J., Chung, J. Y., Lee, J. E., Kim, J., Shin, Y.-C., & So, I. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00238 · Cited by 40

Higher Soluble Amyloid β Concentration in Frontal Cortex of Young Adults than in Normal Elderly or Alzheimer's Disease

Helmond, Z. V., Miners, J. S., Kehoe, P. G., & Love, S. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00374.x · Cited by 42

Catalytic antibodies to amyloid β peptide in defense against Alzheimer disease

Taguchi, H., Planque, S. A., Nishiyama, Y., Szabo, P., Weksler, M. E., Friedland, R. P., & Paul, S. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.03.004 · Cited by 40

Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures

Mota, S. I., Ferreira, I. L., Pereira, C., Oliveira, C. R., & Rego, A. C. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455322 · Cited by 42

An Azobenzene Photoswitch Sheds Light on Turn Nucleation in Amyloid-β Self-Assembly

Doran, T. M., Anderson, E. A., Latchney, S. E., Opanashuk, L. A., & Nilsson, B. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn2001188 · Cited by 40

Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity

Lin, C., Cheng, Y., Li, H., Chiu, P., Chang, Y., Ho, Y., & Lai, T. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.10.009 · Cited by 39

The neglected co-star in the dementia drama: the putative roles of astrocytes in the pathogeneses of major neurocognitive disorders

Jo, W. K., Law, A. C. K., & Chung, S. K. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.171 · Cited by 40

APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38

Moro, M. L., Giaccone, G., Lombardi, R., Indaco, A., Uggetti, A., Morbin, M., Saccucci, S., Fede, G. D., Catania, M., Walsh, D. M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1061-x · Cited by 39

Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons

Ovsepian, S. V., Antyborzec, I., O’Leary, V. B., Záborszky, L., Herms, J. W., & Dolly, J. O. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0583-x · Cited by 40

The effect of solvents on the conformations of Amyloid β-peptide (1–42) studied by molecular dynamics simulation

Cao, Y., Li, J., Li, Y., & Zhu, X. (2008) · Journal of Molecular Structure THEOCHEM · doi:10.1016/j.theochem.2008.10.003 · Cited by 40

Phospholipase A2 inhibitors protect against prion and Aβ mediated synapse degeneration

Bate, C., Tayebi, M., & Williams, A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-13 · Cited by 39

Metals and cholesterol: two sides of the same coin in Alzheimer’s disease pathology

Wong, B. X. W., Hung, Y. H., Bush, A. I., & Duce, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00091 · Cited by 41

Aβ peptide conformation determines uptake and interleukin-1α expression by primary microglial cells

Parvathy, S., Rajadas, J., Ryan, H. S., Vaziri, S., Anderson, L., & Murphy, G. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.011 · Cited by 39

Geniposide Protects Primary Cortical Neurons against Oligomeric Aβ1-42-Induced Neurotoxicity through a Mitochondrial Pathway

Zhao, C., Lv, C., Li, H., Du, S., Liu, X., Li, Z., Xin, W., & Zhang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152551 · Cited by 39

Aβ Induces Excitotoxicity Mediated by APC/C-Cdh1 Depletion That Can Be Prevented by Glutaminase Inhibition Promoting Neuronal Survival

Fuchsberger, T., Martínez‐Bellver, S., Giraldo, E., Teruel‐Martí, V., Lloret, A., & Viña, J. (2016) · Scientific Reports · doi:10.1038/srep31158 · Cited by 39

Modulation of Alzheimer's amyloid β peptide oligomerization and toxicity by extracellular Hsp70

Rivera, I., Capone, R. F., Cauvi, D. M., Arispe, N. J., & Maio, A. D. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0839-0 · Cited by 41

The Effect of Lycium barbarum Polysaccharides on Pyroptosis-Associated Amyloid β1-40 Oligomers-Induced Adult Retinal Pigment Epithelium 19 Cell Damage

Yang, M., So, K., Lo, A., & Lam, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134658 · Cited by 40

Biotin–avidin interaction-based screening assay for Alzheimer’s β-peptide oligomer inhibitors

LeVine, H. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.04.036 · Cited by 39

The Dying of the Light: Mitochondrial Failure in Alzheimer's Disease

Young, K. J., McArdle, M. J., & Bennett, J. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111487 · Cited by 39

Sugar-based peptidomimetics inhibit amyloid β-peptide aggregation

Dorgeret, B., Khemtémourian, L., Correia, I., Soulier, J. L., Lequin, O., & Ongeri, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.10.008 · Cited by 39

Dutch and arctic mutant peptides of β amyloid1–40 differentially affect the FGF-2 pathway in brain endothelium

Solito, R., Corti, F., Fossati, S., Mezhericher, E., Donnini, S., Ghiso, J. A., Giachetti, A., Rostagno, A. A., & Ziche, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.002 · Cited by 38

Modulation of Amyloid β Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate

Fernàndez‐Busquets, X., Ponce, J., Bravo, R., Arimon, M., Martiáñez, T., Gella, A., Cladera, J., & Durany, N. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383787 · Cited by 38

Amyloid-β peptide induces temporal membrane biphasic changes in astrocytes through cytosolic phospholipase A2

Hicks, J., Lai, Y., Sheng, W., Yang, X., Zhu, D., Sun, G. Y., & Lee, J. C. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.07.027 · Cited by 40

Appearance of annular ring-like intermediates during amyloid fibril formation from human serum albumin

Arya, S., Kumari, A., Dalal, V., Bhattacharya, M., & Mukhopadhyay, S. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp03782d · Cited by 38

An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Aβ1–42 peptide oligomerization: Application to anti‐Alzheimer's drug discovery

Brinet, D., Kaffy, J., Oukacine, F., Glumm, S., Ongeri, S., & Taverna, M. (2014) · Electrophoresis · doi:10.1002/elps.201400271 · Cited by 30

Arginine and Disordered Amyloid-β Peptide Structures: Molecular Level Insights into the Toxicity in Alzheimer’s Disease

Coskuner‐Weber, O., & Wise-Scira, O. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001389 · Cited by 38

In Silicoandin VitroStudy of Binding Affinity of Tripeptides to Amyloid β Fibrils: Implications for Alzheimer’s Disease

Man, V. H., Šipošová, K., Bednáriková, Z., Antošová, A., Nguyen, T. T., Gažová, Z., & Li, M. S. (2015) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b00006 · Cited by 38

The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer’s Disease

Park, H., Kang, S., Nam, E., Suh, Y., & Chang, K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00002 · Cited by 38

The Effects of Mobile Phone Radiofrequency Electromagnetic Fields on β-Amyloid-Induced Oxidative Stress in Human and Rat Primary Astrocytes

Tsoy, A., Saliev, T. M., Abzhanova, E., Turgambayeva, A., Kaiyrlykyzy, A., Akishev, M., Saparbayev, S. S., Umbayev, B. A., & Askarova, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.058 · Cited by 39

Cajaninstilbene Acid Ameliorates Cognitive Impairment Induced by Intrahippocampal Injection of Amyloid-β1–42 Oligomers

Wang, L.-S., Xue, T., Liu, X., Zhou, Y., Zhang, M.-D., Liao, Y., Pan, R., & Chang, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01084 · Cited by 38

Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning

Gray, V. E., Sitko, K. A., Kameni, F. Z. N., Williamson, M., Stephany, J. J., Hasle, N., & Fowler, D. M. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400535 · Cited by 39

Early Effects of Aβ Oligomers on Dendritic Spine Dynamics and Arborization in Hippocampal Neurons

Ortiz-Sanz, C., Gaminde‐Blasco, A., Valero, J., Bakota, L., Brandt, R., Zugaza, J. L., Matute, C., & Alberdi, E. M. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00002 · Cited by 37

The traditional uses, secondary metabolites, and pharmacology of Lycopodium species

Wang, B., Guan, C., & Fu, Q. (2021) · Phytochemistry Reviews · doi:10.1007/s11101-021-09746-4 · Cited by 38

In vitroOligomerization and Fibrillogenesis of Amyloid-beta Peptides

Benseny‐Cases, N., Klementieva, O., & Cladera, J. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-5416-4_3 · Cited by 39

Advances on the Understanding of the Origins of Synaptic Pathology in AD

Lacor, P. N. (2007) · Current Genomics · doi:10.2174/138920207783769530 · Cited by 40

Axon degeneration is key component of neuronal death in amyloid-β toxicity

Alobuia, W. M., Xia, W., & Vohra, B. P. S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.013 · Cited by 38

All-atom molecular dynamics studies of the full-length β-amyloid peptides

Luttmann, E., & Fels, G. (2005) · Chemical Physics · doi:10.1016/j.chemphys.2005.08.071 · Cited by 37

Size-Dependent Interaction of Amyloid β Oligomers with Brain Total Lipid Extract Bilayer─Fibrillation Versus Membrane Destruction

Mrđenović, D., Majewska, M., Pieta, I. S., Bernatowicz, P., Nowakowski, R., Kutner, W., Lipkowski, J., & Pięta, P. (2019) · Langmuir · doi:10.1021/acs.langmuir.9b01645 · Cited by 39

Telomerase increasing compound protects hippocampal neurons from amyloid beta toxicity by enhancing the expression of neurotrophins and plasticity related genes

Baruch-Eliyahu, N., Rud, V., Braiman, A., & Priel, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-54741-7 · Cited by 37

The Acute Effects of Amyloid-Beta1–42 on Glutamatergic Receptor and Transporter Expression in the Mouse Hippocampus

Yeung, J. H. Y., Palpagama, T. H., Tate, W. P., Peppercorn, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01427 · Cited by 39

‘O-Acyl isopeptide method’ for the efficient preparation of amyloid β peptide 1–42 mutants

Sohma, Y., Chiyomori, Y., Kimura, M., Fukao, F., Taniguchi, A., Hayashi, Y., Kimura, T., & Kiso, Y. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.037 · Cited by 38

Effects of Amyloid β-Peptides on the Lysis Tension of Lipid Bilayer Vesicles Containing Oxysterols

Kim, D. H., & Frangos, J. A. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.114983 · Cited by 37

Amyloid-β(1–42) Protofibrils Formed in Modified Artificial Cerebrospinal Fluid Bind and Activate Microglia

Paranjape, G. S., Terrill, S. E., Gouwens, L. K., Ruck, B. M., & Nichols, M. R. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9424-6 · Cited by 39

Alzheimer Peptides Aggregate into Transient Nanoglobules That Nucleate Fibrils

Luo, J., Wärmländer, S. K. T. S., Gräslund, A., & Abrahams, J. P. (2014) · Biochemistry · doi:10.1021/bi5003579 · Cited by 39

Plasma Acetylcholinesterase Activity Correlates with Intracerebral β-Amyloid Load

Alkalay, A., Rabinovici, G. D., Zimmerman, G., Agarwal, N., Kaufer, D., Miller, B. L., Jagust, W. J., & Soreq, H. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310010007 · Cited by 38

LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity

Granic, I., Masman, M. F., Mulder, C. K., Nijholt, I. M., Naudé, P., de Haan, A., Borbély, E., Penke, B., Luiten, P. G. M., & Eisel, U. L. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1297 · Cited by 37

Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats

Granic, I., Nyakas, C. J., Luiten, P. G. M., Eisel, U. L. M., Halmy, L. G., Groß, G., Schoemaker, H., Möller, A., & Nimmrich, V. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.013 · Cited by 36

Molecular Dynamics Study To Investigate the Effect of Chemical Substitutions of Methionine 35 on the Secondary Structure of the Amyloid β (Aβ(1−42)) Monomer in Aqueous Solution

Triguero, L., Singh, R. R., & Prabhakar, R. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp0771872 · Cited by 37

Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro

Morinaga, A., Ono, K., Takasaki, J., Ikeda, T., Hirohata, M., & Yamada, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.01.011 · Cited by 37

Studies of Polymorphism of Amyloid-β 42 Peptide from Different Suppliers

Suvorina, M. Y., Selivanova, O. M., Grigorashvili, E. I., Никулин, А. Д., Marchenkov, V. V., Surin, A. K., & Galzitskaya, O. V. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150147 · Cited by 37

Epidermal growth factor prevents oligomeric amyloid-β induced angiogenesis deficits in vitro

Koster, K. P., Thomas, R., Morris, A. W. J., & Tai, L. M. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16669956 · Cited by 36

Microglia Do Not Take Up Soluble Amyloid-beta Peptides, But Partially Degrade Them by Secreting Insulin-degrading Enzyme

Fu, H., Liu, B., Li, L., & Lemere, C. A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.07.020 · Cited by 36

A nexus of miR-1271, PAX4 and ALK/RYK influences the cytoskeletal architectures in Alzheimer's Disease and Type 2 Diabetes

Majumder, P., Chanda, K., Das, D., Singh, B. K., Chakrabarti, P., Jana, N. R., & Mukhopadhyay, D. (2021) · Biochemical Journal · doi:10.1042/bcj20210175 · Cited by 38

The Armc10/SVH gene: genome context, regulation of mitochondrial dynamics and protection against Aβ-induced mitochondrial fragmentation

Serrat, R., Mirra, S., Figueiro‐Silva, J., Navas-Pérez, E., Quevedo, M., López‐Doménech, G., Podlesniy, P., Ulloa, F., García‐Fernàndez, J., Trullás, R., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.121 · Cited by 37

Effects of G33A and G33I Mutations on the Structures of Monomer and Dimer of the Amyloid-β Fragment 29−42 by Replica Exchange Molecular Dynamics Simulations

Lü, Y., Wei, G., & Derreumaux, P. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp110269a · Cited by 36

Beta-Amyloid Oligomers Activate Apoptotic BAK Pore for Cytochrome c Release

Kim, J., Yang, Y., Song, S. S., Na, J., Oh, K. J., Jeong, C., Yu, Y. G., & Shin, Y. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.07.074 · Cited by 40

Copper inducing Aβ42 rather than Aβ40 nanoscale oligomer formation is the key process for Aβ neurotoxicity

Jin, L., Wu, W., Li, Q., Zhao, Y., & Li, Y. (2011) · Nanoscale · doi:10.1039/c1nr11029b · Cited by 36

Amyloid‐β aggregates formed at polar–nonpolar interfaces differ from amyloid‐β protofibrils produced in aqueous buffers

Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., & Rosenberry, T. L. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20189 · Cited by 37

The expression of p75 neurotrophin receptor protects against the neurotoxicity of soluble oligomers of β-amyloid

Costantini, C., Bianca, V. D., Formaggio, E., Chiamulera, C., Montresor, A., & Rossi, F. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.09.004 · Cited by 36

Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine

van Gijsel‐Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., Reggi, M. L. D., & Gharib, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194586 · Cited by 35

Peptide Oligomerization Memory Effects and Their Impact on the Physical Stability of the GLP-1 Agonist Liraglutide

Bothe, J. R., Andrews, A., Smith, K. J., Joyce, L. A., Krishnamachari, Y., & Kashi, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00106 · Cited by 35

Effect of amyloid peptides on serum withdrawal-induced cell differentiation and cell viability

Yi Peng, W. A. N. G., Wang, Z. F., Zhang, Y., Tian, Q., & Wang, J. Z. (2004) · Cell Research · doi:10.1038/sj.cr.7290249 · Cited by 36

Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease

Lee, J., Kweon, H., Cho, E., Lee, J.-Y., Byun, H.-R., Kim, D. H., Kim, Y. H., Han, P., & Koh, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.06.037 · Cited by 36

Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer’s Disease

Deng, Y., Wei, J., Cheng, J., Zhong, P., Zhe, X., Liu, A., Lin, L., Chen, S., & Yan, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160167 · Cited by 36

Binding of protofibrillar Aβ trimers to lipid bilayer surface enhances Aβ structural stability and causes membrane thinning

Dong, X., Sun, Y., Wei, G., Nussinov, R., & Ma, B. (2017) · Physical Chemistry Chemical Physics · doi:10.1039/c7cp05959k · Cited by 34

Synergistic approaches unraveling regulation and aggregation of intrinsically disordered β-amyloids implicated in Alzheimer’s disease

Kumari, A., Rajput, R., Shrivastava, N., Somvanshi, P., & Grover, A. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.03.014 · Cited by 35

Protective effects of tanshinone IIA on SH-SY5Y cells against oAβ1–42-induced apoptosis due to prevention of endoplasmic reticulum stress

Yang, W., Zhang, J., Shi, L., Ji, S., Yang, X., Zhai, W., Zong, H.-F., & Qian, Y. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.011 · Cited by 35

BAP31 deficiency contributes to the formation of amyloid‐β plaques in Alzheimer's disease by reducing the stability of RTN3

Wang, T., Chen, J., Hou, Y., Yu, Y. W., & Wang, B. (2018) · The FASEB Journal · doi:10.1096/fj.201801702r · Cited by 35

Use of a Stereochemical Strategy To Probe the Mechanism of Phenol-Soluble Modulin α3 Toxicity

Yao, Z., Cary, B. P., Bingman, C. A., Wang, C., Kreitler, D. F., Satyshur, K. A., Forest, K. T., & Gellman, S. H. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b00349 · Cited by 38

Label-Free Detection and Self-Aggregation of Amyloid β-Peptides Based on Plasmonic Effects Induced by Ag Nanoparticles: Implications in Alzheimer’s Disease Diagnosis

García-Leis, A., & Sánchez‐Cortés, S. (2021) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c00093 · Cited by 35

Sciadopitysin: active component fromTaxus chinensisfor anti-Alzheimer's disease

Gu, Q., Li, Y., Chen, Y., Yao, P.-F., & Ou, T. (2013) · Natural Product Research · doi:10.1080/14786419.2013.790031 · Cited by 34

The stimulation of dendritic cells by amyloid beta 1–42 reduces BDNF production in Alzheimer’s disease patients

Ciaramella, A., Salani, F., Bizzoni, F., Orfei, M. D., Langella, R., Angelucci, F., Spalletta, G., Taddei, A. R., Caltagirone, C., & Bossù, P. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.04.001 · Cited by 35

Randomization of Amyloid‐β‐Peptide(1‐42) Conformation by Sulfonated and Sulfated Nanoparticles Reduces Aggregation and Cytotoxicity

Saraiva, A. M., Cardoso, I., Saraiva, M. J., Tauer, K., Pereira, M. D. C., Coelho, M. A. N., Möhwald, H., & Brezesinski, G. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900448 · Cited by 36

Intracerebroventricular injection of beta-amyloid in mice is associated with long-term cognitive impairment in the modified hole-board test

Schmid, S., Jungwirth, B., Gehlert, V., Blobner, M., Schneider, G. H., Kratzer, S., Kellermann, K., & Rammes, G. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.02.007 · Cited by 34

Physiological and pathological effects of amyloid-β species in neural stem cell biology

Liste, I., Bernabeu-Zornoza, A., Coronel, R., Palmer, C., Monteagudo, M., & Zambrano, A. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262571 · Cited by 40

Synthesis of d-amino acid peptides and their effect on beta-amyloid aggregation and toxicity in transgenic Caenorhabditis elegans

Jagota, S., & Rajadas, J. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0386-2 · Cited by 35

Single-Molecule Imaging Reveals Aβ42:Aβ40 Ratio-Dependent Oligomer Growth on Neuronal Processes

Johnson, R. D., Schauerte, J. A., Chang, C.-C., Wisser, K. C., Althaus, J. C., Carruthers, C. J. L., Sutton, M. A., Steel, D. G., & Gafni, A. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2012.12.051 · Cited by 34

Estrogen Receptors Are Involved in the Neuroprotective Effect of Silibinin in Aβ1–42-Treated Rats

Song, X., Liu, B., Cui, L., Zhou, B., Liu, L., Liu, W., Yao, G., Xia, M., Hayashi, T., Hattori, S., et al. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2481-3 · Cited by 34

Physiologically-relevant levels of sphingomyelin, but not GM1, induces a β-sheet-rich structure in the amyloid-β(1-42) monomer

Owen, M. C., Kulig, W., Poojari, C., Róg, T., & Strodel, B. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.026 · Cited by 34

Fluorescence Detection and Dissociation of Amyloid‐β Species for the Treatment of Alzheimer's Disease

Lv, G., Shen, Y., Zheng, W., Yang, J., Li, C., & Lin, J. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900054 · Cited by 34

Aggregation States of Aβ1–40, Aβ1–42 and Aβp3–42 Amyloid Beta Peptides: A SANS Study

Festa, G., Mallamace, F., Sancesario, G. M., Corsaro, C., Mallamace, D., Fazio, E., Arcidiacono, L., Sakai, V. G., Senesi, R., Preziosi, E., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174126 · Cited by 34

Two distinct β-sheet structures in Italian-mutant amyloid-beta fibrils: a potential link to different clinical phenotypes

Hubin, E., Deroo, S., Schierle, G. S. K., Kaminski, C. F., Serpell, L. C., Subramaniam, V., van Nuland, N. A. J., Broersen, K., Raussens, V., & Sarroukh, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1983-2 · Cited by 36

The Mitochondrial Secret(ase) of Alzheimer's Disease

Young, K. J., & Bennett, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100360 · Cited by 34

Amyloid β peptides overexpression in retinal pigment epithelial cells via AAV-mediated gene transfer mimics AMD-like pathology in mice

Prasad, T., Zhu, P., Verma, A., Chakrabarty, P., Rosario, A. M., Golde, T. E., & Li, Q. (2017) · Scientific Reports · doi:10.1038/s41598-017-03397-2 · Cited by 35

RACK1 is involved in β-amyloid impairment of muscarinic regulation of GABAergic transmission

Liu, W., Dou, F., Feng, J., & Yan, Z. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.017 · Cited by 33

Dynamics of Aβ42 Reduction in Plasma, CSF and Brain of Rats Treated with the γ-Secretase Modulator, GSM-10h

Hawkins, J., Harrison, D. C., Ahmed, S. F., Davis, R. P., Chapman, T. D., Marshall, I., Smith, B. B., Mead, T. L., Medhurst, A. D., Giblin, G. M. P., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000324511 · Cited by 33

Structure-activity relationships of sugar-based peptidomimetics as modulators of amyloid β-peptide early oligomerization and fibrillization.

Kaffy, J., Brinet, D., Soulier, J., Khemtemourian, L., Lequin, O., Taverna, M., Crousse, B., & Ongeri, S. (2014) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2014.09.031 · Cited by 22

Differential effects of amyloid-beta 1–40 and 1–42 fibrils on 5-HT 1A serotonin receptors in rat brain

Verdurand, M., Chauveau, F., Daoust, A., Morel, A., Bonnefoi, F., Liger, F., Bérod, A., & Zimmer, L. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.12.008 · Cited by 33

In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis

Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210207200 · Cited by 1,015

P1‐167: Effects of beta‐amyloid oligomers on neuronal viability and microglial activation

Ferrera, D., Canale, C., Benfenati, F., & Gasparini, L. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.04.173

Effect of different Aβ1-42 assemblies on neuronal cell viability

Morkūnienė, R., Čižas, P., Budvytytė, R., Valinčius, G., & Borutaitė, V. (2010) · Lithuanian University of Health Sciences

P4–014: Divergent cytotoxic mechanisms of soluble and fibrillar forms of AAY in human cortical neurons

Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1752

Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of β-amyloid peptide

Ward, R. V., JENNINGS, K. H., Jepras, R., Neville, W. A., OWEN, D. E., HAWKINS, J., Christie, G., Davis, J. B., George, A. R., Karran, E. H., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480137 · Cited by 153